 |
Our mission at ImQuest Life Sciences is to discover and develop new and novel, cutting edge, therapies for the treatment of infectious disease, cancer, and inflammation. Our scientific expertise in these therapeutic areas is based on decades of experience in the preclinical and clinical development of drugs, vaccines and other biologics, providing ImQuest Life Sciences staff significant perspective on the properties of successful drug candidates.
A key component in our drive to develop novel drugs is the formation of drug development alliances with individuals and organizations that provide the cutting edge medicinal chemistry required for the next generation of drugs. ImQuest Life Sciences has formed a drug development alliance with Samjin Pharmaceutical Co. Ltd. of Korea, providing ImQuest Life Sciences with access to Samjin's highly successful chemistry team and rights of first refusal to all of Samjin's highly potent compounds for infectious disease and cancer.
ImQuest Life Sciences has launched drug development projects in the following areas of research and is on target to file INDs and initiate clinical trials in each of these areas over the next 12-24 months.
|
|
|
| |
|
| Meet ImQuest Life Sciences's Staff at the Following Scientific Meetings: |
 |
International Conference on Antiviral Research (Palm Springs, CA, May 2007)
American Association of Pharmaceutical Science-Biotechnology (San Diego, CA June 2007)
|
|
DART-HIV (Cancun, Mexico, December 2006) |
|
Internscience Conference of Antimicrobial Agents and Chemotherapy (Chicago, September 2007)
DART-HCV (Hawaii, December 2007)
|
|
| |
|
